FDA Grants Breakthrough Device Designation for CurveBeam AI’s OssView™ Bone Fragility Software
<HATFIELD, Penn. - September 12, 2022> CurveBeam AI, Ltd announced its medical diagnostic software, OssView™, has received US Food and Drug Administration (FDA) Breakthrough Device Designation. OssView calculates a Structural Fragility Score (SFS), which determines bone microstructural deterioration, a highly…